The use of psychotropic interventions to manage the inappropriate behaviors displayed by students who are emotionally disturbed (ED) has continued to increase over the past several decades. To date, few studies have investigated the use of psychotropic medications among students with ED placed in the most restrictive educational settings (i.e., residential facilities). For this study, medication records from 137 students placed in three nonpublic residential schools were reviewed. This survey found that medication rates varied from 65% to 94%, with an overall medication rate of 76% among students placed in residential care. Other findings of interest included (a) Caucasian students were more likely to receive medication therapy than their African American or Hispanic peers, and (b) students placed in a residential center specializing in treating students with a history of substance abuse were less likely to receive medication therapy.
Get full access to this article
View all access options for this article.
References
1.
ConnorD. F., BooneR. T., SteingardR. J., LopezI. D., & MelloniR. H. (2003). Psychopharmacology and aggression: II. A meta-analysis of nonstimulant medication effects on overt aggression-related behaviors in youth with SED. Journal of Emotional and Behavioral Disorders, 11, 157–168.
2.
ConnorD. F., OzbayrakK. R., HarrisonR. J., & MelloniR. H. (1998). Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment. Journal of Child and Adolescent Psychopharmacology, 8, 27–38.
3.
CullinanD., GadowK. D., & EpsteinM. H. (1987). Psychotropic drug treatment among learning disabled, educable mentally retarded, and seriously emotionally disturbed students. Journal of Abnormal Child Psychology, 15, 469–477.
4.
DulcanM. K. (2007). Helping parents, youth, and teachers understand medications for behavioral and emotional problems.Washington, D. C: American Psychiatric Press.
5.
EpsteinM. H., SinghN. N., LuebkeJ., & StoutC. E. (1991). Psychopharmacological intervention. II: Teacher perceptions of psychotropic medication for students with learning disabilities. Journal of Learning Disabilities, 24, 477–483.
6.
FalkK. B., & WehbyJ. H. (2001). The effects of peer-assisted learning strategies on the beginning reading skills of young children with emotional or behavioral disorders, Behavioral Disorders, 26, 344–359.
7.
FishbeinW. (1997). But is it ethical to withhold treatment to which some children respond?Brown University Child & Adolescent Behavior Letter, 13, 1–3.
8.
FornessS. R., KavaleK. A., SweeneyD. P., & CrenshawT. M. (1999). The future of research and practice in behavioral disorders: Psycho-pharmacology and its school implications. Behavioral Disorders, 24, 305–317.
9.
GadowK. D. (1997). An overview of three decades of research in pediatric psychopharmacoepidemiology. Journal of Child and Adolescent Psychopharmacology, 7, 219–236.
10.
GreenbaumP. E., & DedrickR. F. (1996). National adolescent and child treatment study (NACTS): Outcomes for children with serious emotional and behavioral disturbance. Journal of Emotional and Behavioral Disorders, 4, 130–146.
11.
HahnB. A. (1995). Children's health: Racial and ethnic differences in the use of prescription medications. Pediatrics, 101, 727–732.
12.
HalforsD., & FallonT. (1998). An examination of psychotropic drug treatment for children with serious emotional disturbance. Journal of Emotional and Behavioral Disorders, 6, 56–66.
13.
JensenP. S., KettleL., RoperM. T., SloanM. T., DulcanM. K., & HovenC. (1999). Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 797–804.
14.
LinK. L., & PolandR. E. (1995). Ethnicity, culture, and psychopharmacology. In BloomF. E., & KupferD. J. (Eds.), Psychopharmacology: The fourth generation of progress (pp. 1907–1917). New York: Raven Press.
15.
MattisonR. E. (1999). Use of psychotropic medications in special education students with serious emotional disturbance. Journal of Child and Adolescent Psychopharmacology, 9, 149–155.
MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073–1086.
18.
National Institute of Mental Health. (2003). Attention deficit disorder withhyperactivity. Retrieved December 10, 2006, from http://www.nimh.nih.gov
19.
OswaldD. P. (2002). The new medical model and beyond: A response to Forness and Kavale. Behavioral Disorders, 27, 155–157.
20.
PappadopulosE., MacIntyreJ. C., CrimsonM. L., FindlingR. L., MaloneR. P., & DerivanA. (2003). Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 145–161.
21.
RunnheimV. A., FrankenbergerW. R., & HazelkornM. N. (1996). Medicating students with emotional and behavioral disorders and ADHD: A state survey. Behavioral Disorders, 21, 306–314.
22.
RyanJ. B., ReidR., & EllisC. (In press). A survey of special educator knowledge regarding psychotropic interventions for students with emotional and behavioral disorders. Remedial & Special Education.
23.
SaferD. J., & MaleverM. (2000). Stimulant treatment in Maryland public schools. Pediatrics, 106, 533–539.
24.
SaferD. J., & ZitoJ. M. (2000). Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of attention deficit hyperactivity disorder. In GreenhillL., & OsmonB. (Eds.), Ritalin: Theory and practice, (2nd ed., pp. 7–26) Larchmont, NY: Liebert.
25.
SchurS. B., SikichL., FindlingR. L., MaloneR. P., CrimsonM. L., & DerivanA. (2003). Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: A review. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 132–143.
26.
Stanford Research Institute. (2008). Special education elementary longitudinal (SEEL) study of elementary and middle school students receiving special education. Retrieved July 6, 2008, from www.seels.net/search/tables/1/si1b8b1frm.html
27.
SussmanL. K., RobinsL. N., & EarlsF. (1987). Treatment-seeking for depression by black and white Americans. Social Science Medicine, 24, 187–196.
28.
SweeneyD. P., FornessS. R., & LevittJ. G. (1998). An overview of medications commonly used to treat behavioral disorders associated with autism, Tourette syndrome, and pervasive developmental disorders. Focus on Autism and Other Developmental Disabilities, 13, 144–150.
29.
ThomasC. P., ConradP., RosemaryC., & GoodmanE. (2006). Trends in the Use of Psychotropic Medications Among Adolescents, 1994 to 2001. Psychiatric Services, 57, 63–69.
U.S. Department of Education. (2004). Twenty-sixth annual report to Congress on the implementation of the Individuals With Disabilities Education Act.Washington, DC: Author.
32.
WerryJ. S. (1993). Introduction: A guide for practitioners, professionals, and public. In WerryJ. S., & AmanM. G. (Eds.), Practitioner's guide to psychoactive drugs for children and adolescents (pp. 3–21). New York: Plenum.
33.
ZitoJ. M., SaferD. J., dosReisS., GardnerJ. F., BolesM., & LynchF. (2000). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283, 1025–1030.
34.
ZitoJ. M., SaferD. J., dosReisS., MadgerL. S., & RiddleM. A. (1997). Methylphenidate patterns among Medicaid youth. Psychopharmacology Bulletin, 33, 143–147.
